Label-based quantitation

Show results for

Proteomics (950)
Unknown (123)
Transcriptomics (25)
Metabolomics (8)
Other (3)
Genomics (3)
Multiomics (1)

Organisms

Homo sapiens (886)
Mus musculus (886)
Aerococcus urinae NBRC 15544 = CCUG 36881 (885)
Allexis (885)
Canis lupus familiaris (885)
Carya cathayensis (885)
Clostridioides difficile 630 (885)
Cyanophora paradoxa (885)
Ensifer adhaerens (885)
Enterococcus faecalis (885)
Globicatella sanguinis (885)
Histomonas meleagridis (885)
Human immunodeficiency virus 1 (885)
Homo sapiens (26)
Mus musculus (3)
Pseudomonas aeruginosa (2)
Escherichia coli (2)
Rattus norvegicus (2)
Helianthus annuus (1)
Thermoplasma acidophilum DSM 1728 (1)
Bacteria (1)
Metallosphaera sedula (1)
Streptococcus gordonii (1)
Streptomyces coelicolor (1)
Staphylococcus aureus (1)
Macaca fascicularis (1)
Aspergillus niger (1)
Eimeria tenella (1)
Haemaphysalis sp. CJ-2015 (1)
Gallus gallus (1)

Organisms

Macaca fascicularis (1)
Rattus norvegicus (1)
Homo sapiens (1)

Repository

pride (886)
MassIVE (46)
biostudies-arrayexpress (23)
PeptideAtlas (8)
iProX (7)
MetaboLights (6)
GPMDB (3)
ENA (3)
geo (2)
GNPS (2)
jPOST (1)
PanoramaPublic (1)
PAXDB (1)

Tissue

Cell culture (250)
Brain (54)
Epithelial cell (46)
Permanent cell line cell (36)
Liver (34)
Blood plasma (30)
Heart (24)
Plant cell (22)
Blood serum (20)
Blood (17)
Fibroblast (17)
T cell (17)
Lung (15)
Macrophage (15)
Cell suspension culture (14)
Kidney (12)
Leaf (12)
Blood cell (11)
Colon (9)
Hepatocyte (9)
Primary cell (9)
Melanocyte (8)
Pancreas (8)
Skin (8)
Others (7)
Blood platelet (7)
Dendritic cell (7)
Embryonic stem cell (7)
Feces (6)
Prokaryotic cell (6)

Disease

Breast cancer (22)
Disease free (21)
Colon cancer (19)
Cervix carcinoma (9)
Severe acute respiratory syndrome (9)
Acute leukemia (8)
Malignant neoplasm of ovary (8)
Melanoma (6)
Pancreatic cancer (6)
Tuberculosis (6)
Alzheimer's disease (5)
Cardiovascular system disease (5)
Type 2 diabetes mellitus (5)
Brain cancer (4)
Brain glioblastoma multiforme (4)
COVID-19 (4)
Glioblastoma (4)
Lung adenocarcinoma (4)
Prostate cancer (4)
Skin cancer (4)
Tularemia (4)
Not Available (3)
Lymphoma (3)
Metabolic dysfunction-associated steatotic liver disease (3)
Neuroblastoma (3)
Non-small cell lung carcinoma (3)
Obesity (3)
Obesity (3)
Osteosarcoma (3)
Not applicable (1)

Technology Type

Mass Spectrometry (886)
Shotgun proteomics (584)
Bottom-up proteomics (158)
Data-dependent acquisition (122)
Affinity purification coupled with mass spectrometry proteomics (84)
Gel-based experiment (42)
Data-independent acquisition (19)
Top-down proteomics (18)
SWATH MS (13)
SRM/MRM (11)
Chemical cross-linking coupled with mass spectrometry proteomics (8)
Mass spectrometry (6)
HDMSE (6)
Affinity proteomics (4)
MSE (3)
All-ion fragmentation (2)
DiaPASEF (1)
Immunopeptidomics (1)
Metaproteomics (1)
Proteogenomics (1)

Instrument Platform

Q Exactive (14)
LTQ Orbitrap Velos (10)
Orbitrap Fusion Lumos (8)
QExactive (8)
Q Exactive HF (4)
Impact HD (3)
Instrument (3)
LTQ Orbitrap Elite (3)
Liquid Chromatography MS - positive - reverse phase (3)
LTQ (2)
Liquid Chromatography MS - negative - reverse phase (2)
TripleTOF 5600+|1002584 (1)
MS:1000490 (1)
Orbitrap Fusion (1)
Q Exactive HF-X (1)
TimsTOF HT (1)
TripleTOF 5600 (1)
MSSimulator (1)
SYNAPT HDMS (Waters) (1)
5975C Series GC/MSD (Agilent) (1)

Publication Date

2021 (123)
2022 (118)
2023 (113)
2025 (99)
2024 (94)
2026 (87)
2020 (76)
2018 (66)
2019 (62)
2017 (41)
2016 (28)
2014 (26)
2015 (21)
2013 (6)
2010 (5)
2008 (4)
2007 (3)
2012 (2)
2011 (2)
2009 (2)
2004 (2)

UNIPROT ID/AC

128UP_DROME (1)
140U_DROME (1)
1433E_DROME (1)
1433Z_DROME (1)
18C_DROME (1)
2AAA_DROME (1)
2ABA_DROME (1)
3HIDH_DROME (1)
41_DROME (1)
5HT1R_DROME (1)
5HT2A_DROME (1)
5HT2B_DROME (1)
5NT3B_DROME (1)
6PGD_DROME (1)
6PGL_DROME (1)
7227.FBpp0070052 (1)
7227.FBpp0070054 (1)
7227.FBpp0070575 (1)
7227.FBpp0071052 (1)
7227.FBpp0073560 (1)
7227.FBpp0073589 (1)
7227.FBpp0074882 (1)
7227.FBpp0075642 (1)
7227.FBpp0076767 (1)
7227.FBpp0077066 (1)
7227.FBpp0077184 (1)
7227.FBpp0077279 (1)
7227.FBpp0078249 (1)
7227.FBpp0080495 (1)
7227.FBpp0081059 (1)

ENSEMBL ID

ENSG00000170477 (6)
ENSG00000247315 (5)
ENSG00000147251 (1)
ENSMUSG00000021039 (1)
ENSMUSG00000027651 (1)
ENSMUSG00000090272 (1)
ENSMUSG00000098557 (1)
ENSMUSP00000140201 (1)
ENSMUSP00000141097 (1)
ENSMUSP00000141542 (1)
ENSMUSP00000141637 (1)

CHEBI ID

CHEBI:89746 (2)
CHEBI:75457 (2)
CHEBI:134127 (1)
CHEBI:142346 (1)
CHEBI:185590 (1)
CHEBI:185033 (1)
CHEBI:185082 (1)
CHEBI:184433 (1)
CHEBI:185588 (1)
CHEBI:185161 (1)
CHEBI:185584 (1)
CHEBI:184906 (1)
CHEBI:185183 (1)
CHEBI:185582 (1)
CHEBI:185580 (1)
CHEBI:184474 (1)
CHEBI:184829 (1)
CHEBI:185175 (1)
CHEBI:184782 (1)
CHEBI:185578 (1)
CHEBI:184420 (1)
CHEBI:185576 (1)
CHEBI:184776 (1)
CHEBI:184405 (1)
CHEBI:185575 (1)
CHEBI:185573 (1)
CHEBI:185571 (1)
CHEBI:185568 (1)
CHEBI:185567 (1)
CHEBI:184791 (1)

Metabolite Name

2-Monolinoleoylglycerol (1)
Monohexadecanoylglycerol (1)
Monopalmitoylglycerol (1)
C12:0 (1)
C20:5 (1)
PS(DIME(11,5)/MONOME(13,5)) (1)
4,4,10-Trimethyl-1,11-bis(3-methylbut-2-en-1-yl)-10-(4-methylpent-3-en-1-yl)-9-(2-methylpropanoyl)-3-oxatricyclo[7.3.1.0²,⁷]trideca-2(7),5-diene-8,13-dione (1)
2-{[3,4-dihydroxy-5,6-bis({[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]oxy})oxan-2-yl]methoxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate (1)
{2-[(7Z,10Z,13Z,16Z)-docosa-7,10,13,16-tetraenoyloxy]-3-(tetracosanoyloxy)propoxy}[2-(methylamino)ethoxy]phosphinic acid (1)
TG(20:1(11Z)/22:2(13Z,16Z)/20:2(11Z,14Z)) (1)
1-(8-{[6-({[3,5-dihydroxy-6-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxy-6-methoxy-3-methylnaphthalen-2-yl)ethan-1-one (1)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({[3-(methylsulfanyl)propyl]thio(carbonoimidyl)}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid (1)
(2E)-N-{2-[5,5'-dihydroxy-3'-(2-{[(2E)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}ethyl)-1H,1'H-[4,4'-biindole]-3-yl]ethyl}-3-(4-hydroxyphenyl)prop-2-enimidic acid (1)
(2R,3R)-2-(3,4-Dihydroxyphenyl)-6-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyloxy)-3,4-dihydro-2H-1-benzopyran-4-yl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (1)
2-(Hydroxymethyl)-6-[(3,4,5-trihydroxy-6-{[16-hydroxy-2,6,6,10,11-pentamethyl-14-(6-methyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hept-5-en-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-yl]oxy}oxan-2-yl)methoxy]oxane-3,4,5-triol (1)
5-(6-hydroxy-4-{5-[(E)-2-[6-hydroxy-3-(3-hydroxyphenyl)-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-4-yl]ethenyl]-2-(4-hydroxyphenyl)-1-benzofuran-3-yl}-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzofuran-3-yl)benzene-1,3-diol (1)
6-(16'-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-15'-oloxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
3-[({2-[(3-{[4-({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-1,2-dihydroxy-3,3-dimethylbutylidene]amino}-1-hydroxypropylidene)amino]ethyl}sulfanyl)carbonyl]-4-hydroxy-4-phenylbutanoic acid (1)
4-({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-N-[2-({2-[(11E)-icos-11-enoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-3,3-dimethylbutanimidic acid (1)
(1R,2R,3R,11S,12S,14R,26R)-5,6',7',12-tetrahydroxy-6-methoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1³,¹¹.0²,¹³.0⁴,⁹.0¹⁵,²³.0¹⁶,²⁰]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate (1)
Ps(14:1(9z)/20:5(5z,8z,11z,14z,17z)) (1)
2-[6'-(5,7-Dihydroxy-4-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-2-yl)-2',3',4,4',5,6-hexahydroxy-[1,1'-biphenyl]-2-yl]-5,7-dihydroxy-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate (1)
Heptacosane-6,8-dione (1)
3,4,5-trihydroxy-6-{[5-hydroxy-14-(1-hydroxy-6-methylhept-5-en-2-yl)-2,11,15-trimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-8-yl]oxy}oxane-2-carboxylic acid (1)
2-[(7-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-3-yl)oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate (1)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (1)
2-[2-({7-[(3-carboxy-3-{2-[(6-carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-2-oxoethyl}propanoyl)oxy]-11,16,18-trihydroxy-19-[(1-hydroxyethylidene)amino]-5,9-dimethylicosan-6-yl}oxy)-2-oxoethyl]butanedioic acid (1)
(6-{4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-8-yl]-3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-8-yl}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxidanesulfonic acid (1)
[6,7,8,11,12,13,23-heptahydroxy-3,16-dioxo-21-(3,4,5-trihydroxybenzoyloxy)-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10,12,14-hexaen-22-yl]oxidanesulfonic acid (1)
N-Isobutyl-2E,4Z-octadecadienoyl amine (1)

First Public Date

2014 (3)

Modification

4x(15)N labeled L-arginine (3)
2x(15)N labeled L-lysine (2)
4x(2)H labeled dimethylated L-lysine (2)
4 (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
Heavy form - site K (1)
Light form - site K (1)

Study type

Transcription profiling by array (15)
Unknown experiment type (3)
Other (2)
RNA-seq of coding RNA (2)
Comparative genomic hybridization by array (1)

Release Date

2022 (16)
2020 (13)
2016 (12)
2023 (11)
2025 (10)
2018 (9)
2017 (9)
2015 (8)
2021 (8)
2019 (8)
2013 (7)
2012 (6)
2010 (6)
2009 (5)
2011 (4)
2008 (4)
2014 (4)
2007 (3)
2024 (3)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (68)
Analytics Core Facility Essen (ACE), Chemische Biologie, Universität Duisburg-Essen, ZMB, Germany (27)
Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, OncoProteomics Laboratory, Amsterdam, Netherlands (10)
Centre for Proteome Research, University of Liverpool, Liverpool, UK (9)
OncoProteomics Laboratory, Dept of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands (6)
Bioplatforms Australia (4)
Farnusch Kaschani, Analytics Core Facility Essen (ACE), Chemische Biologie, Universität Duisburg-Essen, ZMB, Germany (4)
Keck MS & Proteomics Resource Yale School of Medicine (4)
Systems Arbovirology, Leibniz Institute of Virology, Hamburg, Germany (4)
University of Edinburgh (4)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (3)
Charles Perkins Centre, School of Medical Sciences, University of Sydney, Sydney, Australia. (3)
Department of Biomedical Sciences, University of Sassari, Italy (3)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA (3)
Department of Convergence Medicine, Convergence Medicine Research Center/Biomedical Research Center, Asan Medical Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. (3)
Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO 63110, USA. (3)
Department of Molecular Pathology and Biology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic (3)
The University of Sydney (3)
The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 USA (3)
University of Sydney (3)
V. L. Talrose Institute for Energy Problems of Chemical Physics, N. N. Semenov Federal Research Center of Chemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia (3)
Washington University in St. Louis (3)
COI-NDM (University of Oxford) (2)
CRUK -CRUK Scotland nstitute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (2)
Cancer Science Institute of Singapore (CSI), National University of Singapore (NUS) (2)
Cleveland Clinic Lerner Research Institute Cardiovascular and Metabolic Sciences (2)
Cornell University (2)
Department of Biomedical Sciences, University of Sassari, Sassari, Italy (2)
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (2)
Department of Genetic Medicine and Development, Faculty of Medicine, University of Geneva, Switzerland (2)

Tags

xref:PubMed:15150374 (1)
xref:PubMed:15557180 (1)

Previous page
1 / 112
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 112
Next page

Sort by:

Relevance

Page size

An Integrated Quantitative Proteomics Workflow for Biomarker Discovery and Validation in Plasma

Blood plasma is one of the most widely used samples for biomarker discovery research as well as clinical investigations for diagnostic and therapeutic purposes. However, the plasma proteome is extremely complex due to its wide dynamic range of protein concentrations and the presence of high-abundanc...

ORGANISM(S): Homo sapiens (Human)

2020-09-07 | PXD017834 | Pride

SysQuan: repurposing SILAC mice for affordable absolute quantitation of the human proteome

Relative quantitation, used by most MS-based proteomics laboratories to determine protein fold-changes, requires that samples are processed and analyzed together to enable best comparability through minimizing batch differences. This limits the detection of subtle but relevant changes in heterogeneo...

ORGANISM(S): Mus musculus (Mouse) Homo sapiens (Human)

2025-06-16 | PXD057266 | Pride

Proteomics Silac Stable isotope Targeted proteomics Absolute quantitation

iTRAQ-Based and Label-Free Proteomics Approaches for Studies of Human Adenovirus Infections.

Not available

S-EPMC3608280 | biostudies-literature

Evaluation of Spectral Counting for Relative Quantitation of Proteoforms in Top-Down Proteomics.

Not available

S-EPMC6178225 | biostudies-literature

Quantitative characterization of the neuropeptide level changes in dorsal horn and dorsal root ganglia regions of the murine itch models

In this study, we performed a label-free relative quantitation to identify the peptide candidates correlated with itch sensation in murine models. We tested two different itch models-the AEW model (known commonly as the dry skin model) and the MC903 model. Performed peptide extraction from the dorsa...

ORGANISM(S): Mus musculus (Mouse)

2020-01-23 | PXD015949 | Pride

Lc-ms Extracted ion chromatogram Label-free quantitation

A statistical framework for protein quantitation in bottom-up MS-based proteomics.

Not available

S-EPMC2723007 | biostudies-literature

gpGrouper: A Peptide Grouping Algorithm for Gene-Centric Inference and Quantitation of Bottom-Up Proteomics Data.

Not available

S-EPMC6210220 | biostudies-literature

An Optimized Chromatographic Strategy for Multiplexing In Parallel Reaction Monitoring Mass Spectrometry: Insights from Quantitation of Activated Kinases.

Not available

S-EPMC5294213 | biostudies-literature

Benchmarking label-free quantification based on data-independent acquisition (DIA) workflows

Label-free quantification based on data-independent acquisition (DIA) workflows is increasingly popular. Several software tools have been recently published or are commercially available. The present study focuses on the critical evaluation of three different software packages (Progenesis, synapter ...

ORGANISM(S): Homo sapiens (Human) Escherichia coli Saccharomyces cerevisiae (Baker's yeast)

2017-04-06 | PXD001240 | Pride

Human Yeast E.coli

In-depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-assisted label-free protein quantitation and microarray gene expression approach.

Not available

S-EPMC3270101 | biostudies-literature

Previous page
1 / 112
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 112
Next page

Sort by:

Relevance

Page size

1112 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

ENSEMBL ID

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets